BioCentury
ARTICLE | Finance

3Q14 Stock Wrap-Up: Going big again

Winners, losers in biotech stock tiers in 3Q14

October 6, 2014 7:00 AM UTC

For the second quarter in a row, only the large caps finished in the black in 3Q14. In the over $5 billion segment, which was up 9%, gainers outnumbered decliners 22-9, while the decliners led in all other segments by nearly two to one, at 443-234. (see "Results by Market Cap").

Sigma-Aldrich Corp. led large caps, finishing the quarter up 34%, on the late September announcement that Merck KGaA would buy the tool company for $17 billion...